Increased expression of TIGIT in a variety of tumours, including melanoma, acute myeloid leukaemia, oesophageal SCC, neuroblastoma and HNSCC, is closely associated with tumour progression [56,59,62]. Here, TIGIT is linked to head and neck squamous cell carcinoma.